Fusidic acid eye drops for bacterial pink eye
Part of Eyes & vision, Infections clinical trials.
This trial tests an antibiotic eye drop called fusidic acid for bacterial conjunctivitis (pink eye). It may help clear the infection if you have had symptoms for less than 48 hours and have not used other eye treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have bacterial pink eye in at least one eye, with yellow/green discharge and a red eye.
- You have not used any eye drops or ointments for pink eye in the last 14 days.
- You have tested negative for viral pink eye in both eyes.
- You agree not to wear contact lenses or use eye makeup during the study.
- You are not pregnant, breastfeeding, or at risk of pregnancy without using birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye medication called SUM-191 for treating bacterial conjunctivitis (a bacterial infection that causes pink eye). The study has three parts: first testing safety in healthy people, then in people with the infection itself.
This trial tests a new type of antibiotic eye drop for people with serious eye infections that don't respond to standard antibiotics. It aims to see if these drops can safely treat the infection and help improve vision.
This study tests whether an anti-swelling eye drop (fluorometholone) helps people with bacterial eye ulcers heal faster when added to standard antibiotics. It may be an option if you have a bacterial ulcer and have already started antibiotic drops.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.
This study tests a new light-based treatment for a rare fungal infection of the eye (Fusarium keratitis) that can cause vision loss. It aims to see if this therapy can fight the infection and help preserve or improve your vision.
Hear when a new Bacterial Conjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.